Spark Therapeutics jumped into existence late in 2013 with a pipeline of gene therapy projects spawned by investigators at the Children’s Hospital of Philadelphia and quickly followed up this year with a $73 million round, breakthrough drug status and a $280 million partnership with Pfizer. Now it’s ending its freshman year by filing to go public.

…read more

Source: Upstart Spark is ready to ring in the New Year with $86M gene therapy IPO


0 No comments